Food and Drug Administration approved the first oral GLP-1 receptor agonist for chronic weight managementushering in a new era of accessibility for obesity and cardiometabolic care
Be gentle with your skin following clear + brilliant laser treatment
The risk of hypoglycaemia (low blood sugar) is generally low with GLP-1 medications when used alone
For individuals considering either compound, understanding the biochemical differences, clinical evidence, and personal biomarker context becomes essential before provider consultation
Chen D, Wang Y, Wang X, Si X, Weng Y, Liu S, Pan W, Xu Y, Wang Y, Zhang Y (2025) Nuclear receptor coactivator 4 linked to follicular dysplasia in polycystic ovary syndrome: a key regulator that aggravates ovarian granulosa cells ferritinophagy and ferroptosis